Concerto Biosciences vs InnoSIGN

Concerto Biosciences logo

Concerto Biosciences

It takes a village — of microbes

25 employees · est. 2020 · Cambridge, United States

VS
InnoSIGN logo

InnoSIGN

Comprehensive Pathway Analysis

5 employees · est. 2022 · Eindhoven, The Netherlands

Concerto Biosciences is the older company (2020 vs 2022); Concerto Biosciences is the larger of the two.

Side-by-Side Comparison

Concerto Biosciences InnoSIGN
Founded
2020 older 2022
Headquarters
Cambridge, United States Eindhoven, The Netherlands
Employees
25 larger 5
Industry
Big Data, Biopharma, Biotechnology Biotechnology, Life Sciences
Funding Stage
Series A Series A
Total Funding
$26.01M $8.00M
Funding Rounds
2 1
Services
Microbial Ingredient Discovery, Microbial Product Efficacy Translation, Ecological Dataset Generation, Microbial Behavior Prediction Comprehensive Disease Analysis, Data Interpretation from Omics, Actionable Insights for Drug Development
Target Customers
Skincare Industry, Healthcare Providers, Nutrition Companies, Biotech Researchers Pharmaceutical Companies, Biotech Firms, Research Institutions, Healthcare Professionals
Taxonomy
Microbial TherapiesMicrobial Community ScreeningAI-driven Microbial EcologyLive BiotherapeuticsSkin Health SolutionsEczema Treatment +9 BiotechPrecision MedicinePathway AnalysisMRNA ProfilingSignaling PathwaysDisease Driver Events +9
Website
concertobio.com innosignbio.com
Concerto Biosciences logo

About Concerto Biosciences

Concerto Biosciences, founded in 2020, stands at the forefront of integrating big data and biotechnology to unlock vast microbial potentials. Operating out of the United States, the company capitalizes on its slogan, "It takes a village — of microbes." By harnessing its proprietary kChip platform, C...

InnoSIGN logo

About InnoSIGN

InnoSIGN, founded in 2022 and headquartered in The Netherlands, is a dynamic player in the Biotechnology and Life Sciences industries. The company’s tagline, "Comprehensive Pathway Analysis," encapsulates its mission to revolutionize disease understanding. InnoSIGN’s distinguishing feature is its b...

Also comparing in this category

Comparing more than these two?

Get Concerto Biosciences, InnoSIGN and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Concerto Biosciences compare?

A PDF of Concerto Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Concerto Biosciences was founded in 2020, based in Cambridge, United States, with 25 employees. Concerto Biosciences, founded in 2020, stands at the forefront of integrating big data and biotechnology to unlock vast microbial potentials. Operating out of the United States, the company capitalize. InnoSIGN was founded in 2022, based in Eindhoven, The Netherlands, with 5 employees. InnoSIGN, founded in 2022 and headquartered in The Netherlands, is a dynamic player in the Biotechnology and Life Sciences industries. The company’s tagline, "Comprehensive Pathway Analysis," encapsul.
Concerto Biosciences has raised $26.01M and InnoSIGN $8.00M. Latest stage: Concerto Biosciences Series A, InnoSIGN Series A.
Both work in Biotechnology and Life Sciences.

Compare Concerto Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Concerto Biosciences on 9 Jun 2026, and InnoSIGN on 21 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes